Barry Ticho - Jan 31, 2023 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role: Chief Medical Officer
Signature: /s/ Stephen Tulipano, Attorney-in-Fact
Stock symbol: STOK
Transactions as of: Jan 31, 2023
Transactions value $: -$61,810
Form type: 4
Date filed: 2/2/2023, 05:32 PM
Previous filing: Dec 9, 2022
Next filing: Feb 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STOK	Common Stock	Sale	-$2K	-200	-0.15%	$10.00	131K	Jan 31, 2023	Direct	F1
transaction	STOK	Common Stock	Sale	-$57.1K	-5.71K	-4.37%	$10.02	125K	Feb 1, 2023	Direct	F1, F2
transaction	STOK	Common Stock	Sale	-$2.67K	-267	-0.21%	$10.00	125K	Feb 2, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.03 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.03 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.